EUVIMEDEUVIMED entdecken
Open Access

Theranostic Probiotic Engineered Living Materials That Dynamically Respond to Inflammation Markers

Gokce Altin-Yavuzarslan iD, Sierra M Brooks iD, James O Park, Kevin B Reed, McKenna Flynn, Olivia L Lanier iD, Hongyuan Lu, Hal S Alper iD, Alshakim Nelson iD

Advanced Healthcare Materials · 2026-01 · 15 (3)

DOI: 10.1002/adhm.202503809 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, online erschienen am 26.09.2025. Verfasst von Gokce Altin-Yavuzarslan und 8 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Engineering and Sciences Institute, University of Washington, 3946 W Stevens Wy NE, Seattle, WA, 98195, USA. Hauptthemen laut MEDLINE: Probiotics, Inflammation, Theranostic Nanomedicine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 79 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIBIB NIH HHS, National Science Foundation, Congressionally Directed Medical Research Programs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development of smart, implantable devices localized at the site of inflammation to conditionally and proactively combat active inflammation for inflammatory bowel disease (IBD), has the potential to transform the patient's quality of life compared to conventional treatment modalities. Engineered probiotic organisms can enable dynamic production of therapeutic compounds in response to inflammatory biomarkers. However, delivery and localization of these engineered organisms to the site of inflammation requires their integration into a material or device that sustains their viability and metabolic activity. To this end, a 3D printed engineered living material (ELM) is developed using an engineered probiotic organism ( E. coli Nissle 1917) with genetic circuits to sense biomarkers for inflammation and respond with the production of anti‐inflammatory compounds. These organisms are incorporated into poly(ethylene glycol) diacrylate (PEGDA) resins for the light‐based 3D printing of 3D constructs. The organisms are physically encapsulated within the PEGDA and are fully viable and metabolically active. The 3D printed ELM devices are able to detect clinically relevant amounts of nitric oxide as an inflammatory biomarker and respond with the production of tryptamine or 1‐acetyl‐3‐carboxyl‐β‐carboline as representative anti‐inflammatory agents. Additionally, the ELM devices are efficacious in treating in vitro models of inflammation, including murine macrophages and intestinal epithelial cells. Looking forward, these ELM devices could serve as theranostic modalities for the long‐term treatment of inflammatory disorders such as IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProbioticsInflammationTheranostic NanomedicineAnimalsPolyethylene GlycolsMiceBiomarkersHumansPrinting, Three-DimensionalEscherichia coliInflammatory Bowel Diseases

Stichwörter der Autor:innen

E. coli nissle 1917engineered living materialsinflammation treatmentprobiotic therapysmart drug deliverystimuli‐responsive materialstheranostics

Substanzen

Polyethylene GlycolsBiomarkerspoly(ethylene glycol)diacrylate

Autor:innen und Institutionen

  • Molecular Engineering and Sciences Institute, University of Washington, 3946 W Stevens Wy NE, Seattle, WA, 98195, USA.
  • Department of Chemistry, University of Washington, 3790 Okanogan Lane Bagley Hall 036, Seattle, WA, 98195, USA.
  • Department of Chemistry and Chemical Biology, Northeastern University, 815 Columbus Ave EXP Building 330, Boston, MA, 02120, USA.
  • McKetta Department of Chemical Engineering, The University of Texas at Austin, 200 E Dean Keeton St, Austin, TX, 78712, USA.
  • Department of Surgery, University of Washington, 1959 NE Pacific Street Box 356410, Seattle, WA, 98195, USA.
  • Department of Molecular Biosciences, The University of Texas at Austin, Norman Hackerman Building 100 E 24th St #2.606, Austin, TX, 78712, USA.

ORCID-Profile: Gokce Altin-Yavuzarslan, Sierra M Brooks, Olivia L Lanier, Hal S Alper, Alshakim Nelson

Förderung

  • NIBIB NIH HHS
  • National Science Foundation
  • Congressionally Directed Medical Research Programs
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Altin-Yavuzarslan, G., Brooks, S. M., Park, J. O., Reed, K. B., Flynn, M., Lanier, O. L., Lu, H., Alper, H. S., & Nelson, A. (2026). Theranostic Probiotic Engineered Living Materials That Dynamically Respond to Inflammation Markers. Advanced Healthcare Materials, 15(3). https://doi.org/10.1002/adhm.202503809

Vancouver

Altin-Yavuzarslan G, Brooks SM, Park JO, Reed KB, Flynn M, Lanier OL, et al. Theranostic Probiotic Engineered Living Materials That Dynamically Respond to Inflammation Markers. Advanced Healthcare Materials. 2026;15(3). doi:10.1002/adhm.202503809

BibTeX
@article{AltinYavuzarslan2026,
  author = {Altin-Yavuzarslan, Gokce and Brooks, Sierra M and Park, James O and Reed, Kevin B and Flynn, McKenna and Lanier, Olivia L and Lu, Hongyuan and Alper, Hal S and Nelson, Alshakim},
  title = {Theranostic Probiotic Engineered Living Materials That Dynamically Respond to Inflammation Markers},
  journal = {Advanced Healthcare Materials},
  year = {2026},
  volume = {15},
  number = {3},
  doi = {10.1002/adhm.202503809}
}
Kostenlos starten →